UNSPSC 51283222: Spiramycin i

This classification denotes a macrolide antibiotic C43H74N2O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 033ECH6IFG, chemically known as leucomycin v, 9-o-((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)-, but more generally known as spiramycin i, which bears US NIH Compound Identifier 158334. Most nations, for tariff and trade purposes, schedule spiramycin i under HS 29419000 and SITC 54139. As of Q4 2014, SPIRAMYCIN I remains US FDA's Preferred Term for this commodity.

SMILES: C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@@H](O4)C)N(C)C.

UNSPSC 51283222 Spiramycin (Commodity) represents pharmaceutical products and related medical supplies procured by state and local health agencies, though recent state and local solicitations tagged with this code show substantial scope mismatch. Seminole County, Florida, Tallahassee, Texas HHS, and the City of Tampa have all posted opportunities under or near this code in the past six months, but their actual procurements span naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing — none of which align with spiramycin's narrow antibiotic scope. The work being solicited includes emergency medical supplies for fire rescue divisions, state pharmacy benefit management initiatives, and bulk pharmaceutical supply agreements across public health networks. Issuing bodies include state health agencies (Texas HHS Commission), county health departments (Seminole County), municipal fire departments (City of Tampa), and state cooperative purchasing consortiums (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP).

Recent activity shows geographic spread across Florida, Texas, and Minnesota, with participation from Oregon through MMCAP's multistate purchasing vehicle. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies including respiratory equipment and cardiac monitoring electrodes for the Tampa Fire Department Rescue Division, estimated at $700,000 and sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multiple contracts for generic pharmaceuticals and OTC products through authorized wholesalers with contract effectiveness July 1, 2026. The code appears to show little relevant activity aligned with spiramycin specifically, with posted opportunities reflecting broader pharmaceutical and medical supply procurement rather than this antibiotic product line.